<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">mouse</item><item key="factors"><item><item key="GSM767665"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767666"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767665"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767666"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767669"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767670"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767669"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767665"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767666"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767670"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767669"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767666"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767670"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767669"><item key="LCMV INFECTION TYPE">acute</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item><item><item key="GSM767665"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">secondary</item></item></item><item><item key="GSM767666"><item key="LCMV INFECTION TYPE">chronic</item><item key="CD8 T CELL EFFECTOR TYPE">primary</item></item></item></item><item key="id">6555</item><item key="pop_total">0</item><item key="platform">6</item><item key="summary_wrapped">Understanding the response of memory CD8 T cells to persistent antigen re-stimulation and the role of CD4 T cell help is critical to the...</item><item key="pubmed_id">21856186</item><item key="geo_gse_id">E-GEOD-30962</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">16</item><item key="tags"><item>cell</item><item>lymphocytic choriomeningitis</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">primary-and-secondary-cd8-t-cells-during-acute-and</item><item key="geo_id_plat">E-GEOD-30962_A-AFFY-45</item><item key="name">Primary and secondary CD8 T cells during acute and chronic LCMV infection</item><item key="created">Nov.11, 2014</item><item key="summary">Understanding the response of memory CD8 T cells to persistent antigen re-stimulation and the role of CD4 T cell help is critical to the design of successful vaccines for chronic diseases. However, studies comparing the protective abilities and qualities of memory and na&#239;ve cells have been mostly performed in acute infections, and little is known about their roles during chronic infections. Herein, we show that memory cells dominate over na&#239;ve cells and are protective when present in large enough numbers to quickly reduce infection.  In contrast, when infection is not rapidly reduced, memory cells are quickly lost, unlike na&#239;ve cells.  This loss of memory cells is due to (i) an early block in cell proliferation, (ii) selective regulation by the inhibitory receptor 2B4,  and (iii) increased reliance on CD4 T cell help.  These findings have important implications towards the design of T cell vaccines against chronic infections and tumors. 16 samples are analyzed: 3 replicates of secondary effector CD8 P14 T cells at day 8 post-acute lymphocytic choriomeningitis virus (LCMV) infection; 4 replicates of secondary effector CD8 P14 T cells at day 8 post-chronic LCMV infection; 4 replicates of primary effector CD8 P14 T cells at day 8 post-acute LCMV infection; and 5 replicates of primary effector CD8 P14 T cells at day 8 post-chronic LCMV infection.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-30962</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-30962/samples/</item></data></biogps>
